National Institute of Health to Fund Preclinical

LOS ANGELES, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs...

Related Keywords

United States ,Americans ,Peter Clark ,Ken Schultz ,National Institute Of Diabetes ,National Institute Of Health ,Trethera Corporation ,Small Business Technology Transfer ,National Institute ,Kidney Diseases ,Trethera Scientific Advisory Board ,Investor Relations ,Private Securities Litigation Reform Act ,Mmunology ,Rethera ,Cla ,Crohnsdisease ,